Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | NEK2 | P51955 | 1/20 | 0.40 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.40 |
| ▸ | EP300 | Q09472 | 1/20 | 0.39 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.39 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.39 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.37 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.37 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29589969 | 1.00 | MAPT (0.46) | MAPTGAAALDH1A1TSHRTP53 | |
| Hydrochloric Acid SCHEMBL29953389 | 0.98 | MAPT (0.45) | MAPTGAAALDH1A1TSHRTP53 | |
| Hydrochloric Acid SCHEMBL29956265 | 0.95 | MAPT (0.43) | MAPTGAAALDH1A1TSHRTP53 | |
| SCHEMBL29837163 | 0.84 | ENPP2 (0.39) | MAPTGAAALDH1A1TSHRTP53 | |
| SCHEMBL20312265 | 0.80 | MAPT (0.41) | MAPTGAAALDH1A1TSHRTP53 | |
| SCHEMBL30253598 | 0.78 | ENPP2 (0.46) | MAPTGAAALDH1A1TSHRTP53 | |
| SCHEMBL13299608 | 0.78 | TSHR (0.45) | MAPTGAAALDH1A1TSHRTP53 | |
| SCHEMBL1580259 | 0.78 | CHEK1 (0.48) | MAPTGAAALDH1A1TSHRKDM4E | |
| SCHEMBL3794447 | 0.78 | GAA (0.40) | MAPTGAAALDH1A1TSHRTP53 | |
| SCHEMBL29276277 | 0.76 | TSPO (0.50) | MAPTGAAALDH1A1TSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014059586-A1 | NOVEL LUMINESCENT MATERIALS | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2014-04-24 | — | — | WO | claimed |
| EP-4741386-A1 | PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Jiangsu Yahong Meditech Co., Ltd. (CN) | 2026-05-13 | — | — | EP | disclosed |
| US-20250388560-A1 | AROMATIC COMPOUND AND USE THEREOF | HITGEN INC (CN) | 2025-12-25 | — | — | US | disclosed |
| EP-4653421-A1 | AROMATIC-RING COMPOUND AND USE THEREOF | Hitgen Inc. (CN) | 2025-11-26 | — | — | EP | disclosed |
| US-20250289799-A1 | PYRIMIDINE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL USE THEREOF | JIANGSU YAHONG MEDITECH CO., LTD. (CN) | 2025-09-18 | — | — | US | disclosed |
| EP-4516779-A1 | PYRIMIDINE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL USE THEREOF | Jiangsu Yahong Meditech Co., Ltd. (CN) | 2025-03-05 | — | — | EP | disclosed |
| WO-2025007777-A1 | PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 江苏亚虹医药科技股份有限公司 | 2025-01-09 | — | — | WO | disclosed |
| US-12187684-B2 | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2025-01-07 | — | — | US | disclosed |
| US-20240352023-A1 | IMIDAZOPYRIMIDINE AND IMIDAZOTRIAZINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2024-10-24 | — | — | US | disclosed |
| US-20240327401-A1 | FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | Evopoint Biosciences Co., Ltd. (CN) | 2024-10-03 | — | — | US | disclosed |
| WO-2003013430-A2 | BENZOQUINONE ANSAMYCINS | KOSAN BIOSCIENCES, INC. (US) | 2003-02-20 | — | — | WO | disclosed |
| US-20030009046-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2003-01-09 | — | — | US | disclosed |
| WO-2002088274-A1 | DOUBLE-SPIRO ORGANIC COMPOUNDS AND ELECTROLUMINESCENT DEVICES | LG CHEM, LTD. (KR) | 2002-11-07 | — | — | WO | disclosed |
| EP-1066303-A1 | TRANSITION METAL COMPOUND CONTAINING CATIONIC GROUPS WHICH IS USED AS AN OLEFIN POLYMERIZATION CATALYST COMPONENT | Basell Polyolefine GmbH (DE) | 2001-01-10 | — | — | EP | disclosed |
| EP-1066330-A1 | CATALYST SYSTEM, METHOD FOR THE PRODUCTION THEREOF, AND THE UTILIZATION THEREOF FOR THE POLYMERIZATION OF OLEFINS | Basell Polyolefine GmbH (DE) | 2001-01-10 | — | — | EP | disclosed |
| WO-1999050312-A1 | CATALYST SYSTEM, METHOD FOR THE PRODUCTION THEREOF, AND THE UTILIZATION THEREOF FOR THE POLYMERIZATION OF OLEFINS | TARGOR GMBH (DE) | 1999-10-07 | — | — | WO | disclosed |
| WO-1999050274-A1 | TRANSITION METAL COMPOUND CONTAINING CATIONIC GROUPS WHICH IS USED AS AN OLEFIN POLYMERIZATION CATALYST COMPONENT | TARGOR GMBH (DE) | 1999-10-07 | — | — | WO | disclosed |
| US-5512246-A | Method and means for detecting polyhydroxyl compounds | Russell, Anthony P. (US) | 1996-04-30 | — | — | US | disclosed |
| EP-0502955-A1 | FLUORINATED SULFONES/KETONES FOR NONLINEAR OPTICS. | DU PONT (US) | 1992-09-16 | — | — | EP | disclosed |
| WO-1991008198-A1 | FLUORINATED SULFONES/KETONES FOR NONLINEAR OPTICS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240327401-A1 | FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | SOS1, SOS2, SOST | MAPT 3241/4885GAA 2467/4885ALDH1A1 3682/4885 |
| US-20250388560-A1 | AROMATIC COMPOUND AND USE THEREOF | RNF213, RNF10, TRIM4 | MAPT 3041/4885GAA 3800/4885ALDH1A1 3247/4885 |
| US-20240352023-A1 | IMIDAZOPYRIMIDINE AND IMIDAZOTRIAZINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | GRM5, GRIK5, GRM1 | MAPT 1597/4885GAA 2946/4885ALDH1A1 2901/4885 |
| US-20250289799-A1 | PYRIMIDINE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL USE THEREOF | USP1, UPP1, UFL1 | MAPT 1959/4885GAA 589/4885ALDH1A1 336/4885 |
| US-12187684-B2 | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof | RORC, RORB, RORA | MAPT 3485/4885GAA 715/4885ALDH1A1 244/4885 |
| US-20030009046-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP1B1, CYP1A1 | MAPT 3748/4885GAA 3987/4885ALDH1A1 198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.